Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Related Citations for PubMed (Select 11919328)

1.

Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.

Oberlander TF, Eckstein Grunau R, Fitzgerald C, Ellwood AL, Misri S, Rurak D, Riggs KW.

Pediatr Res. 2002 Apr;51(4):443-53.

PMID:
11919328
2.

Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.

Oberlander TF, Grunau RE, Fitzgerald C, Papsdorf M, Rurak D, Riggs W.

Pediatrics. 2005 Feb;115(2):411-25.

PMID:
15687451
3.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.

J Clin Psychiatry. 2004 Feb;65(2):230-7.

PMID:
15003078
4.

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Arch Gen Psychiatry. 2006 Aug;63(8):898-906.

PMID:
16894066
5.

Does parenchymal brain injury affect biobehavioral pain responses in very low birth weight infants at 32 weeks' postconceptional age?

Oberlander TF, Grunau RE, Fitzgerald C, Whitfield MF.

Pediatrics. 2002 Sep;110(3):570-6.

PMID:
12205262
6.

Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure.

Oberlander TF, Grunau R, Mayes L, Riggs W, Rurak D, Papsdorf M, Misri S, Weinberg J.

Early Hum Dev. 2008 Oct;84(10):689-97. doi: 10.1016/j.earlhumdev.2008.06.008. Epub 2008 Jul 18.

PMID:
18639992
7.

Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior.

Zeskind PS, Stephens LE.

Pediatrics. 2004 Feb;113(2):368-75.

PMID:
14754951
8.

Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.

Pawluski JL, Brain UM, Underhill CM, Hammond GL, Oberlander TF.

Psychoneuroendocrinology. 2012 Jul;37(7):1019-28. doi: 10.1016/j.psyneuen.2011.11.011. Epub 2011 Dec 15.

PMID:
22177580
9.

Biobehavioral pain responses in former extremely low birth weight infants at four months' corrected age.

Oberlander TF, Grunau RE, Whitfield MF, Fitzgerald C, Pitfield S, Saul JP.

Pediatrics. 2000 Jan;105(1):e6.

PMID:
10617743
10.

The developmental character of cardiac autonomic responses to an acute noxious event in 4- and 8-month-old healthy infants.

Oberlander TF, Grunau RE, Pitfield S, Whitfield MF, Saul JP.

Pediatr Res. 1999 Apr;45(4 Pt 1):519-25.

PMID:
10203144
11.

Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.

Pawluski JL, Galea LA, Brain U, Papsdorf M, Oberlander TF.

Pediatrics. 2009 Oct;124(4):e662-70. doi: 10.1542/peds.2009-0442. Epub 2009 Sep 28.

12.

Self-regulation (recovery) from pain: association between time-based measures of infant pain behavior and prenatal exposure to maternal depression and anxiety.

Warnock FF, Craig KD, Bakeman R, Castral T.

Clin J Pain. 2014 Aug;30(8):663-71. doi: 10.1097/AJP.0000000000000002.

PMID:
24042350
13.

Demographic and therapeutic determinants of pain reactivity in very low birth weight neonates at 32 Weeks' postconceptional Age.

Grunau RE, Oberlander TF, Whitfield MF, Fitzgerald C, Lee SK.

Pediatrics. 2001 Jan;107(1):105-12.

PMID:
11134442
14.

Are there developmentally distinct motor indicators of pain in preterm infants?

Morison SJ, Holsti L, Grunau RE, Whitfield MF, Oberlander TF, Chan HW, Williams L.

Early Hum Dev. 2003 Jun;72(2):131-46.

PMID:
12782425
15.

Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.

Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC.

Psychopharmacology (Berl). 2011 Sep;217(2):211-9. doi: 10.1007/s00213-011-2270-z. Epub 2011 Apr 16.

PMID:
21499702
16.

Bedside application of the Neonatal Facial Coding System in pain assessment of premature neonates.

Grunau RE, Oberlander T, Holsti L, Whitfield MF.

Pain. 1998 Jun;76(3):277-86.

PMID:
9718246
18.

Fluoxetine during pregnancy: impact on fetal development.

Morrison JL, Riggs KW, Rurak DW.

Reprod Fertil Dev. 2005;17(6):641-50. Review.

PMID:
16263070
19.

Body movements: an important additional factor in discriminating pain from stress in preterm infants.

Holsti L, Grunau RE, Oberlander TF, Whitfield MF, Weinberg J.

Clin J Pain. 2005 Nov-Dec;21(6):491-8.

20.

Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density.

Dubnov-Raz G, Hemilä H, Vurembrand Y, Kuint J, Maayan-Metzger A.

Early Hum Dev. 2012 Mar;88(3):191-4. doi: 10.1016/j.earlhumdev.2011.08.005. Epub 2011 Sep 3.

PMID:
21890289
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk